Avandia - MSN Newsfeeds
- Medscape News - The higher death rate in the intensive group was not due to episodes of hypoglycemia or to any single drug, including rosiglitazone , or to a combination of drugs, ACCORD investigators said. ACCORD is an National Heart, Lung, and Blood Institute (NHLBI ...
- MSN MoneyCentral - Adjusted net income excluding selected items(1) Q4 2007: euro 1,429 million (up 4.5%), i.e. euro 1.07 per share (up 5.9%, or up 18.3% in U.S. dollars(2)) FY 2007: euro 6,961 million (up 5.9%), i.e. euro 5.17 per share (up 5.9%, or up 15.7% in U.S ...
- CNBC - GlaxoSmithKline forecast lower 2008 earnings due to falling sales of diabetes drug Avandia and increased generic compet... ...
- MSN UK News - GSK suffered after warnings of lower earnings this year thanks to competition from rivals and lower sales of its Avandia diabetes treatment. Supermarket firm Morrisons also fared well after reports it was taking legal action over being named in a ...
- CNBC - The stock fell 8 percent to hit a three-year low Thursday after the British drug maker reported a 10 percent drop in fourth-quarter profit and said 2008 earnings will decline on generic competition and weaker sales for diabetes pill Avandia. UBS ...
- MSN MoneyCentral - The stock fell 8 percent to hit a three-year low Thursday after the British drug maker reported a 10 percent drop in fourth-quarter profit and said 2008 earnings will decline on generic competition and weaker sales for diabetes pill Avandia. UBS ...
- MSN UK News - GSK suffered after warnings of lower earnings this year thanks to competition from rivals and lower sales of its Avandia diabetes treatment. Supermarket firm Morrisons also fared well after reports it was taking legal action over being named in a ...
- Boston Globe - Q: Some of the patients in the study took Avandia, which previous studies suggested raises the risk of heart problems. Could this be why more patients died? A: Researchers have found no link between Avandia and the higher death rate, or between any ...
- MedicineNet.com - The halting of the trial segment follows recent reports that one of those medications, Avandia ( rosiglitazone ), has been linked to an increased risk of heart attack. But Friedewalt said the drug was not responsible for the deaths. "Because of the ...
- MSN MoneyCentral - Although Glaxo has made significant progress with its late-stage pipeline, we are worried about the recent negative news surrounding the company's second largest selling product, Avandia, as well as generic competition to several other products ...
- Boston Globe - Q: Some of the patients in the study took Avandia, which previous studies suggested raises the risk of heart problems. Could this be why more patients died? A: Researchers have found no link between Avandia and the higher death rate, or between any ...
- Axcess News - Only the drug Avandia that is suspected of being heart-risky came to mind, though not all patients were taking it and of those that were, none showed any signs of the drug itself being to blame. During the study it was learned that about 10 percent of ...
- CNBC - The stock fell 8 percent to hit a three-year low Thursday after the British drug maker reported a 10 percent drop in fourth-quarter profit and said 2008 earnings will decline on generic competition and weaker sales for diabetes pill Avandia. UBS ...
- ninemsn - GlaxoSmithKline , which warned on Thursday its 2008 earnings would fall due to sliding sales of diabetes drug Avandia and more generic competition, was hit after WestLB, Citigroup and Goldman cut their price targets. It ended down 0.7%. It was also ...
- Raleigh News & Observer - The company also is reeling from a substantial decline in sales of its most profitable drug, the diabetes pill Avandia, since a study eight months ago linked it to an increased risk of heart attack. With a business model that depended on the ...
- Stockhouse Canada - GlaxoSmithKline shares dropped 7.6 percent after the British drugmaker reported a 12 percent profit fall in fourth-quarter profit and said this year's earnings would drop as well, hurt by declining sales of diabetes drug Avandia and copycat ...
- Financial Times - But Mr Garnier was unable to do much but express frustration at his most burdensome short-term legacy: falling sales triggered by safety scares last year on Avandia, GSK’s “blockbuster” drug for diabetes. Its rising revenues had been the ...
- Stockhouse Canada - The most anticipated earnings were from GlaxoSmithKline, which said that Q4 operating profit fell 7% Y/Y as sales of Avandia in the US continued to decline. Traders said that GSK's shares dropped off over 10% and its 5Y CDS was 7bp wider at 50/52 ...
- Bloomberg - Europe's biggest drugmaker posted a 10 percent drop in fourth-quarter net income as sales of the Avandia diabetes pill decreased by more than half. The company also said earnings will decline this year. Renault plunged 12 percent. Merrill ...
- Bloomberg - Europe's biggest drugmaker posted a 10 percent drop in fourth-quarter net income as sales of the Avandia diabetes pill decreased by more than half. The company also said earnings will decline this year. Renault plunged 12 percent. Merrill ...
Looking for an Avandia lawyer in Washington, DC? Get in touch with one of our Avandia lawyers in Washington, DC now.
Pages: Previous 1 2 3 4 5 6 7 ... Next
This form is secure and encrypted. More information about secure forms and your privacy here.
Avandia Case Evaluation Form
